Palexia

Active Ingredient:: Tapentadol
Origin:: EU

Palexia (Tapentadol)

International sale not permitted. Listed for the domestic market and B2B only.

Tapentadol, the active ingredient in Palexia, is an opioid analgesic presented as a strength/form for oral use. It is indicated for the management of moderate to severe acute pain in adults. GNH India supplies Palexia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH India supplies Palexia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Grünenthal Gmbh

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Tapentadol is used in the management of pain through its action on the central nervous system.

Acute postoperative pain: provides analgesia after surgical procedures.
Chronic musculoskeletal pain: helps control persistent pain from conditions such as osteoarthritis.
Cancer‑related pain: used as part of a multimodal regimen for malignant disease‑associated pain.

How It Works

Tapentadol exerts analgesic effects by combining μ‑opioid receptor agonism with inhibition of norepinephrine reuptake. This dual mechanism reduces pain signal transmission in the central nervous system, offering relief for moderate to severe pain without relying solely on opioid pathways.

Side Effects

Tapentadol may cause a range of adverse reactions, most of which are dose‑dependent and reversible.

Common Side Effects

Nausea
Constipation
Dizziness
Somnolence
Headache
Dry mouth

Serious or Rare Side Effects

Respiratory depression
Seizures
Severe hypotension
Allergic reactions such as rash or angio‑edema
Serotonin syndrome (when combined with serotonergic agents)
Adrenal insufficiency

Precautions & Warnings

When using Palexia, several precautions should be considered to ensure safe and effective therapy.

Assess pain severity: confirm that the pain level warrants opioid treatment.
Evaluate respiratory function: patients with compromised breathing need close monitoring.
Review medical history: consider prior opioid use, substance abuse, or psychiatric conditions.
Monitor for drug dependence: watch for signs of tolerance, misuse, or addiction.
Adjust for renal or hepatic impairment: dose may need modification in organ dysfunction.
Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Tapentadol can interact with several medication classes, influencing its safety and efficacy.

Major Interactions (Avoid)

MAO inhibitors: risk of hypertensive crisis.
CNS depressants: increased risk of respiratory depression and sedation.
Serotonergic drugs: potential for serotonin syndrome.

Moderate Interactions (Monitor Closely)

CYP2D6 inhibitors: may alter tapentadol metabolism.
Diuretics: can enhance hypotensive effects.
Antihistamines: may increase sedation.
Alcohol: additive central nervous system depression.

Frequently Asked Questions

Palexia contains tapentadol, an opioid analgesic prescribed to treat moderate to severe pain. It is commonly used for acute postoperative pain, chronic musculoskeletal pain, and cancer‑related pain as part of a multimodal pain‑management plan.

Tapentadol provides pain relief through a dual mechanism: it activates μ‑opioid receptors and inhibits the reuptake of norepinephrine. This combined action reduces the transmission of pain signals in the central nervous system, offering effective analgesia.

The appropriate dose of Palexia is determined by a qualified prescriber based on the patient’s pain severity, previous opioid exposure, and overall health status. Dosing regimens are individualized and should follow the prescriber’s instructions.

Tapentadol is classified as a pregnancy‑category medication that should be used only if the potential benefit justifies the potential risk to the fetus. It is excreted in breast milk, so breastfeeding mothers should discuss risks with their healthcare provider.

To place an order, submit an enquiry on the Palexia product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details and import documentation.

Compared with traditional opioids such as morphine, tapentadol offers a dual mechanism that may provide effective pain relief with a potentially lower incidence of some opioid‑related side effects. However, individual response varies, and selection should be based on clinical judgment.

Palexia should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children.

Palexia is formulated as an oral tablet that is taken by mouth with or without food, as directed by the prescribing clinician. Swallow the tablet whole; do not crush or chew unless specifically instructed.

Serious risks include respiratory depression, severe hypotension, seizures, and the potential for dependence or abuse. Patients should be monitored for signs of respiratory compromise, excessive sedation, or allergic reactions, especially during treatment initiation.

Palexia is contraindicated in individuals with known hypersensitivity to tapentadol or other opioid analgesics, those who have taken mono‑mono‑amine oxidase inhibitors within the14‑14‑14

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 11 Oct 2026

Disclaimer

International sale not permitted. Listed for the domestic market and B2B only.

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.